ALR Technologies Announces Program for New Diabetes Health Management System

Richmond, Virginia, UNITED STATES

WINSTON-SALEM, NC--(Marketwire - January 30, 2008) - ALR Technologies, Inc. (OTCBB: ALRT) announces the launching of a Diabetes Health Management System to complement ALRT's Constant Health Companion (CHC) patient compliance system. The System is a communications software platform that will enable health professionals to remotely monitor the health progress specifically relating to diabetic patients. This will facilitate more effective and timely communication of care to these patients.

Diabetes is a leading cause of death, serious illness and disability across North America. In the United States, it is estimated that 21 million people have diabetes and an additional 54 million Americans have pre-diabetes. The Canadian Diabetes Association estimates that currently over 2 million Canadians have diabetes and this number is expected to rise to 3 million by the end of the decade. Medical costs due to diabetes and its complications are enormous. In the United States, such costs are estimated to be over $130 billion a year and in Canada, healthcare costs associated with diabetes is $13.2 billion annually.

Diabetes is a lifelong chronic disease with no cure. However, diabetics can take steps to control their disease and reduce the risk of developing the associated serious complications thereby controlling healthcare costs. The Canadian Diabetes Association Clinical Practice Guidelines Expert Committee reports that "Successful diabetes care depends on the daily commitment of person with diabetes mellitus to self-management through the balance of lifestyle and medication. Diabetes care should be organized around a multi- and interdisciplinary diabetes healthcare team that can establish and sustain a communication network between the person with diabetes and the necessary healthcare and community systems." ALRT's Diabetes Health Management System provides an affordable and easy to use communication network as recommended by the Committee. (See:

A Diabetes Health Management System adapted to the Canadian market will also be available. ERS Endocrine Research Inc. ("ERS") Vancouver, Canada will pioneer implementation of a program in February. This will also integrate the System in a new initiative with the newly formed Western Canadian Insulin Pump Centres with offices in B.C. and Alberta.

In addition, ALRT is finalizing plans with a large U.S. self-insured group for a program using the Diabetes Health Management System.

About ERS and the Western Canadian Insulin Pump Centres

ERS conducts research on new drugs and procedures. ERS has published a number of outcome studies in both Type I and Type II diabetes. The Western Canadian Insulin Pump Centres are dedicated to providing easy access for patients with diabetes to insulin pump therapy. The Centres are committed to research on the long-term utility, safety, and effectiveness of this form of therapy.

About ALR Technologies, Inc.

ALR Technologies, Inc. (ALRT) designs and manufactures health management compliance products and monitoring and intervention systems. ALRT's primary system, Constant Health Companion™, fills a serious gap in standard disease management practices. It provides for continued and affordable compliance supervision of patients after they have left the direct care of professionals. More information on ALR Technologies and its products can be found at More information about the Constant Health Companion can be found at:

This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate," "expect," "anticipate," "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange Commission.

Contact Information: Contact: Public Relations 336-577-0329 e-mail: